Immuonutrition support for traumatic brain injury: A systematic review

Wen-tao WANG,Di-wa MA,Xiao-dong NIU,Zhen-wei WANG,Hua-teng DONG,Wei-nian ZHANG
DOI: https://doi.org/10.16151/j.1007-810x.2014.05.027
2014-01-01
Abstract:Objective: To evaluate the effectiveness of immuonutrition support(glutamine) for severe traumatic brain injury(TBI). Methods: The databases such as Pubmed(1966 to July 2013),Embase(1984 to July 2013),Cochrane Library( July 2013),CBM(1978 to July 2013),CNKI( July2013),VIP( July 2013) and Wanfang( July 2013) were electronically searched. Two reviewers independently screened the trials according to inclusions and exclusion criteria,data extraction and systematic reviews. Systematic reviews were performed using the Cochrane Collaboration's RevMan 5. 2 software.Results: Fourteen randomized controlled trials( RCTs) involving 689 participants with severe TBI were included. The results of Systematic Reviews showed that compared with control group,glutamine supplemented enteral nutrition group could reduce the diarrhea[RR = 0. 57,95% CI(0. 36,0. 89),P = 0. 01]and hospital lengths of stay[SMD =- 8. 00,95% CI(- 15. 36,- 0. 64),P = 0. 03]. The glutamine supplemented parenteral nutrition group might reduce the risk of pulmonary infection[RR = 0. 45,95% CI(0.25,0.84),P =0. 01]and the blood glucose level[RR =-2. 31,95% CI(-3. 44,-1. 18),P 0. 01]. Conclusion: Glutamine supplemented enteral nutrition can reduce the diarrhea and hospital lengths of stay,and increase total protein. Glutamine supplemented parenteral nutrition may reduce risk of pulmonary infection and the blood glucose level.
What problem does this paper attempt to address?